Latest News and Press Releases

New Strikes from OMX Derivatives Markets OMX Derivatives Markets introduces new strikes from 2008-06-09 ...

Novo Nordisk today announced headline clinical results from a phase 3 clinical study (LEAD(TM) 6) comparing the effects of liraglutide, a once-daily human GLP-1 analogue, with exenatide, a twice-daily...

Det gennemsnitlige HbA1c-niveau ved studiets begyndelse var en smule over 8%, og det primære målepunkt var ændringen i HbA1c. Patienter, der fik liraglutide, opnåede en reduktion i HbA1c på mere end...

Clinical study shows liraglutide provides statistically significantly better blood glucose control than exenatide Novo Nordisk today announced headline clinical results from a phase 3 clinical study...

Novo Nordisk offentliggjorde i dag hovedkonklusionerne fra et klinisk fase 3-studie (LEAD(TM) 6), der har sammenlignet virkningerne af liraglutide, en human GLP-1-analog til dosering én gang dagligt,...

SMITHTOWN, N.Y., June 6, 2008 (PRIME NEWSWIRE) -- Brad Rock, the Chairman, President & CEO of Bank of Smithtown, participated this week in the International Monetary Conference in Barcelona,...

Rapala VMC Oyj PÖRSSI-ILMOITUS 6.6.2008 klo 19.00 Päivämäärä 6.6.2008 Pörssikauppa Osto Osakelaji A-osake Osakemäärä 1400 kpl Keskihinta/osake 4.54 EUR Ylin hinta/osake 4.58 EUR Alin...

Rapala VMC Corporation Stock Exchange Announcement 6.6.2008 at 19.00 o'clock Date 6.6.2008 Exchange transaction Buy Share class A share Amount 1400 Average price/share 4.54...

Nokia Corporation Announcement 06.06.2008 SHARE REPURCHASES 06.06.2008 In the Helsinki Stock Exchange Trade date 06.06.2008 Bourse Trade ...

SOPRANO OYJ:N OMIEN OSAKKEIDEN HANKINTA 6.6.2008 Päivämäärä 6.6.2008 Pörssikauppa Osto Osakelaji SNO1V Osakemäärä 1000 kpl Keskihinta/osake 0,89 EUR Ylin hinta/osake 0,89 EUR Alin...